Key result
Endocrine pathologies like diabetes, obesity, and thyroid dysfunction linked to increased AFib risk.
Why the study?
Differences in the mechanisms of AF occurrence depending on individual hormonal status require a personalized approach to assessing AF risk factors.
Do endocrinopathies increase the risk of atrial fibrillation and adverse cardiovascular events?
Do endocrinopathies increase the risk of atrial fibrillation and adverse cardiovascular events?
This review highlights the importance of recognizing and managing endocrine pathologies as key risk factors for the prevention and personalized management of atrial fibrillation.
Supports endocrine assessment in AF risk stratification; leaves open whether targeted treatment alters incidence or outcomes.
Atrial fibrillation (AF) is one of the most common forms of cardiac arrhythmia among the population, especially in middle-aged and elderly people. Recently enough data has been accumulated to indicate the difference in the mechanisms of AF occurrence depending on the individual hormonal status, which requires a personalized approach to assessing AF risk factors. The purpose of this article is to analyze the current state of the issue regarding the role of endocrinopathies in the pathogenesis of AF. The authors have presented modern clinical data indicating the influence of endocrine pathology on the risk of AF and its outcomes. It has been shown that diabetes mellitus, obesity and related metabolic syndrome, thyroid dysfunction, sex hormones abnormalities in women are associated with an increased risk of AF, as well as with a high risk of adverse cardiovascular events in the setting of AF. Along with this, the contribution of traditional factors of cardiovascular risk and the importance of their modification to reduce the incidence of AF is shown. The presented analysis shows the importance of taking into account endocrine pathology for the prevention of AF, timely diagnosis and rational therapy of this arrhythmia.
No takes yet. Share an insight, caveat, or question.
Naumova et al. (2023) conducted a review in Atrial fibrillation and endocrinopathies. Endocrine pathologies, including diabetes mellitus, obesity, metabolic syndrome, thyroid dysfunction, and sex hormone abnormalities in women, are associated with an increased risk of atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: